US2010184091A1PendingUtilityA1
Method for determining MIF content
Assignee: CYTOKINE PHARMASCIENCES INCPriority: May 17, 1993Filed: Jun 3, 2009Published: Jul 22, 2010
Est. expiryMay 17, 2013(expired)· nominal 20-yr term from priority
C07K 14/72A61K 2039/505C12N 15/8509A61P 43/00C07K 14/575C12N 15/113C07K 16/26A01K 2267/0337C07K 14/52C12N 15/1138A01K 2217/075C07K 2317/73C07K 16/24A01K 2217/05C12N 15/1136C07K 2317/76A61K 48/00A01K 2267/03Y02A50/30
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to diagnostic methods for determining migration inhibitory factor (MIF) mRNA content in a sample, wherein MIF is human MIF polypeptide having a molecular weight of approximately 12.5 kDa and kits for detecting MIF.
Claims
exact text as granted — not AI-modified1 - 65 . (canceled)
66 . A detection kit, comprising:
(a) an antibody or antigen-binding fragment or fusion protein thereof that specifically binds to human macrophage migration inhibitory factor (MIF) protein, wherein the human MIF protein has a molecular weight of approximately 12.5 kDa as determined by SDS PAGE; (b) a detectable label, whereby the binding of the antibody or antigen-binding fragment or fusion protein to the human MIF protein can be detected.
67 . The kit of claim 66 , wherein (a) is the antibody.
68 . The kit of claim 66 , wherein (a) is the antigen-binding fragment.
69 . The kit of claim 66 , wherein (a) is the fusion protein.
70 . The kit of claim 66 , wherein (a) is the antibody, and the antibody is a monoclonal antibody.
71 . The kit of claim 66 , wherein the detectable label comprises one or more enzymes.
72 . The kit of claim 66 , wherein the detectable label comprises one or more fluorescent dyes.
73 . The kit of claim 66 , wherein the detectable label comprises one or more colored beads.
74 . The kit of claim 66 , wherein the detectable label comprises one or more magnetic beads.
75 . The kit of claim 66 , wherein the human MIF protein exhibits MIF biological activity.
76 . A method of using the diagnostic kit of claim 66 , comprising contacting a sample with (a) and (b).
77 . A method of making the diagnostic kit of claim 66 , comprising providing (a) and (b) together to result in the diagnostic kit.
78 . A method for detecting human macrophage migration inhibitory factor (MIF) protein in a sample, comprising:
(a) contacting the sample with the kit of claim 66 ; and (b) determining the presence or absence of human MIF protein in the sample, wherein if the human MIF protein is detected, then the human MIF protein is present in the sample, and wherein if the human MIF protein is not detected, then the human MIF protein is not present in the sample.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.